Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal.
Fontanet, A
Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal. [electronic resource] - Bone marrow transplantation Sep 2011 - 1272-3 p. digital
Publication Type: Letter
1476-5365
10.1038/bmt.2010.285 doi
Adolescent
Adult
Aged
Anti-Infective Agents--adverse effects
Blood Platelets--physiology
Case-Control Studies
Female
Hematologic Diseases--blood
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Neutrophils--physiology
Trimethoprim, Sulfamethoxazole Drug Combination--adverse effects
Young Adult
Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal. [electronic resource] - Bone marrow transplantation Sep 2011 - 1272-3 p. digital
Publication Type: Letter
1476-5365
10.1038/bmt.2010.285 doi
Adolescent
Adult
Aged
Anti-Infective Agents--adverse effects
Blood Platelets--physiology
Case-Control Studies
Female
Hematologic Diseases--blood
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Neutrophils--physiology
Trimethoprim, Sulfamethoxazole Drug Combination--adverse effects
Young Adult